Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

As a critical molecule in the onset and sustainment of inflammatory response, the receptor for advanced glycation end products (RAGE) has a variety of ligands, such as advanced glycation end products (AGEs), S100/calcium granule protein, and high-mobility group protein 1 (HMGB1). Recently, an increa...

Full description

Bibliographic Details
Main Authors:	Qing Yue, Yu Song, Zi Liu, Lin Zhang, Ling Yang, Jinlong Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Molecules
Subjects:	advanced glycation end-product receptor immune high-mobility group protein 1 nuclear factor kappa-B
Online Access:	https://www.mdpi.com/1420-3049/27/15/4922

Similar Items

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
by: Liuyang Ren, et al.
Published: (2021-01-01)

The role of RAGE, MAPK and NF-κB pathway in the advanced glycation end-products induced HUVECs dysfunction
by: Xun Wang, et al.
Published: (2022-01-01)

Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer
by: Yu Peng, et al.
Published: (2022-12-01)

Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer
by: Taehee Kim, et al.
Published: (2023-05-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Ginseng improves cognitive deficit via the RAGE/NF-κB pathway in advanced glycation end product-induced rats
by: Xiaobin Tan, et al.
Published: (2015-04-01)

Receptors of Advanced Glycation End Product (RAGE) Suppression Associated With a Preserved Osteogenic Differentiation in Patients With Prediabetes
by: Mattabhorn Phimphilai, et al.
Published: (2022-02-01)

Receptor of advanced glycation end product (RAGE) polymorphism and oxidative status in Hashimoto’s thyroiditis in Egyptian female patients: case control study
by: Noura Mostafa Mohamed, et al.
Published: (2022-05-01)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
by: Sang Youl Rhee, et al.
Published: (2018-05-01)

Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
by: Misganaw Asmamaw Mengstie, et al.
Published: (2022-09-01)

Insulin resistance and generation of advanced glycation end products
by: Alvaro Gudiño Gomezjurado, et al.
Published: (2013-04-01)

Detection of receptor for advanced glycation end products (RAGE) and high mobility group protein box 1 HMGB1 levels in patients’ serum with breast cancer
by: Hind Shawqi Zaki, et al.
Published: (2023-01-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)

Comparative evaluation of Salivary-Soluble Receptor for Advanced Glycation End Product (sRAGE) levels among betel chewers and chronic periodontitis patients
by: Rajkumar Chandini, et al.
Published: (2021-01-01)

Pathological Role of Receptor for Advanced Glycation End Products in Calcified Aortic Valve Stenosis
by: Kosuke Saku, et al.
Published: (2020-07-01)

Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE)
by: Agnieszka Nowak, et al.
Published: (2021-12-01)

Glyoxal-Lysine Dimer, an Advanced Glycation End Product, Induces Oxidative Damage and Inflammatory Response by Interacting with RAGE
by: Hee-Weon Lee, et al.
Published: (2021-09-01)

Receptor of advanced glycation end products and cardiovascular risk in elderly with type 2 diabetes mellitus
by: Claudia Borsa, et al.
Published: (2018-02-01)

Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury
by: Taro Miyagawa, et al.
Published: (2022-01-01)

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis
by: Stefania Mardente, et al.
Published: (2018-01-01)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
by: Shou-En Wu, et al.
Published: (2021-10-01)

Do advanced glycation end products contribute to food allergy?
by: P. K. Smith, et al.
Published: (2023-04-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
by: Niki L. Reynaert, et al.
Published: (2023-05-01)

Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
by: Sára Csiha, et al.
Published: (2023-05-01)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
by: Yanyan Kong, et al.
Published: (2020-07-01)

Polymorphisms of Receptor for Advanced Glycation end Products and Risk of Epithelial Ovarian Cancer in Chinese Patients
by: Shuquan Zhang, et al.
Published: (2013-04-01)

Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance
by: Elizabeth del Ruelas Cinco, et al.
Published: (2019-06-01)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
by: Hiromi Abe, et al.
Published: (2023-09-01)

Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways
by: Shaoxiang Weng, et al.
Published: (2013-01-01)

Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women
by: Nabigh A NAJI, et al.
Published: (2021-06-01)

Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes
by: James N. Tsoporis, et al.
Published: (2020-11-01)

Receptor for the Advanced Glycation End Products (<i>RAGE</i>) Pathway in Adipose Tissue Metabolism
by: Klaudia Gutowska, et al.
Published: (2023-07-01)

The plasma level of soluble receptor for advanced glycation end products in systemic lupus erythematosus patients and its relation to disease activity
by: Anna Nashaat Abou-Raya, et al.
Published: (2016-06-01)

Advanced glycation end-products and its soluble receptor are not independent predictors of incident dysglycaemia or metabolic syndrome in women with polycystic ovary syndrome: a prospective observational study
by: Yu Wing Tong, et al.
Published: (2023-05-01)

Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
by: Cheng YZ, et al.
Published: (2014-11-01)

Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01)

Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
by: Somayeh Sadat Heidary, et al.
Published: (2014-01-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
by: Franziska Diekmann, et al.
Published: (2021-08-01)